SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries at two international medical conferences in October 2026. The demonstrations highlight the company's push to make robotic surgery affordable and accessible to a broader global population, a development that could reshape how specialized surgical expertise is delivered across borders.
At the European Association for Cardio-Thoracic Surgery Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient in Bengaluru, India, approximately 7,500 miles away. The feat underscores the potential for telesurgery to bridge geographic gaps in cardiac care, where specialist availability is often concentrated in urban centers. At the Society of Robotic Surgery India Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries involving kidney, colorectal, pediatric urological and gynecological procedures. The range of specialties suggests the technology may be adaptable across diverse surgical disciplines, not just cardiac care.
The SSi MantrAsana console is designed to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization and precise instrument control. As of Oct. 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. The company's product range includes the SSi Mantra surgical robotic system and its SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly and cost-effective surgical robotic solutions.
The implications for the healthcare industry are significant. If telesurgery proves reliable at scale, patients in underserved or remote regions could receive specialized surgical care without traveling long distances, potentially reducing costs and wait times. For investors, the announcement positions SS Innovations as a player in the growing field of robotic-assisted surgery, though the company notes forward-looking risks in its SEC filings. The technology's validation across more than 190 different types of surgical procedures in India provides a foundation for broader adoption. More details are available in the full press release at https://ibn.fm/Ujtlm, and the company's website at ssinnovations.com offers further information. The latest updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII, and the original release can be viewed at www.newmediawire.com.
